Anxiety Treatment Articles & Analysis
7 news found
Anxiety and depression affect millions of individuals worldwide, leading to a significant burden on public health and impacting overall quality of life. ...
However, due to its short half-life, buspirone is prescribed to be taken several times a day for management of anxiety, which can be challenging for patients and may lead to sub-optimal treatment outcomes. ...
Oncomfort, the Belgian inventor of and leader in Digital Sedation - a new method for relieving patients’ pain and anxiety without medication - today announces the completion of a €10 million Series A funding round co-led by two prominent institutional investors: Debiopharm and Crédit Mutuel Innovation. ...
People may live with anxiety for years before they are diagnosed or treated.2 About CTx-2103 and the Formulation Study CTx-2103 is a novel, trimodal, extended-release tablet of buspirone incorporating Cingulate’s proprietary PTR™ drug delivery platform, and is being studied for the treatment of anxiety and/or ...
The transaction allows Neopharmed Gentili to strengthen its portfolio in the neuro-psychiatric area with high value-added drugs for the treatment of insomnia. Neopharmed Gentili, an Italian pharmaceutical company controlled by Ardian in partnership with the Del Bono family, which has historic roots in its territory and is pursuing international growth, announced that it has ...
Oncomfort has just launched SILVA, a new module that enriches its library of solutions for the treatment of anxiety and pain for patients undergoing a medical procedure. ...
GYANT is a triage chatbot that employs AI to help users figure out where they should turn for treatment. GyroGear is a startup focused on helping patients with Parkinson’s disease. ...